Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Not Yet Recruiting NCT05597644

Role of Uterine Artery Embolization in Adenomyosis

Conditions: Adenomyosis

Sex: Female

Ages: 30 Years – 50 Years

Phase: EARLY_PHASE1

Enrollment: 30

Sponsor: Assiut University

Summary

Management of symptomatizing women diagnosed with uterine adenomyosis, by uterine artery angioembolization as a minimally invasive replacement for hysterectomy. This is followed by assessment of the symptoms and MRI of the pelvis after 3 months.

Eligibility Criteria

Inclusion Criteria:Symptomatizing women (pelvic pain and/or bleeding) between ages 30-50 who are not keen on hysterectomy.Exclusion Criteria:Women who desire further child bearing (not completed their family yet).Impaired coagulation profile.Hypersensitivity to intravenous contrast media.Decompensated congestive heart failure.Hypertensive crisis.Stroke or CVA.Renal failure.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05597644). StuddyBuddy aggregates publicly available trial information.